Delivery Order SPE2DB22D2211-SPE2DB24FMPR3
- Not listed
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,563,867,821 units of Bupropion HCL XL 300 mg tablets in 500-count bottles, with a ceiling value of $14,307.61. The contract has a firm fixed price and an ultimate completion date of March 6, 2024. Amerisourcebergen holds a significant Indefinite Delivery...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The delivery order, valued at $12,723.06, is for the supply of 4,564,083,598 units of Bupropion HCL XL 150 mg tablets to DLA Troop Support Medical facilities supporting the Department of Defense. The delivery order falls under a larger indefinite delivery contract (IDC) awarded...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 500 tablets of Bupropion HCL XL 300 mg. The contract has an ultimate completion date of April 28, 2025 and a ceiling value of $9,771.22. The contract is not set-aside and was awarded on April 25, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,026.40 contract is for the delivery of 500 units of the prescription medication Bupropion HCL XL 300 mg tablet. The contract has an ultimate completion date of April 23, 2025 and is not a set-aside. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,249,928 bupropion HCL XL 300 mg tablets in 500-count bottles. The $2,160 contract has an ultimate completion date of April 12, 2024 and is not set aside for any specific business type. Amerisourcebergen Drug Corp, the prime contractor, is the sole awardee on this delivery order, which is issued against a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,330.20 firm fixed-price delivery order is for the supply of 4,564,118,694 units of the generic drug Bupropion HCl 100 mg tablets. The contract has an ultimate completion date of April 1, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of 4,563,783,919 units of Bupropion HCL XL 150 mg tablets in 500-count bottles. The contract has a firm fixed price of $22,368.57 and a period of performance through February 28, 2024. The award is not associated with a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $27,268.05, is for the delivery of bupropion HCL XL 150 mg tablets in 500-count packages. The contract is a firm fixed-price delivery order with a period of performance ending on March 4, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a...
- This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,563,180 units of Bupropion HCL XL 300 mg tablets over the period from December 26, 2023, to December 27, 2023, with a ceiling value of $12,455.50. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen Drug Corp is the prime contractor and holds a significant Indefinite...
- This federal contract award was issued by the U.S. Department of Defense's Medical Supply Chain agency to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the delivery of Bupropion HCL XL 300 mg tablets. The firm-fixed-price delivery order, valued at $44,120.07, has an ultimate completion date of April 23, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued up to...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB24FMPR3Delivery Order
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of 4,563,337,776 units of the prescription drug Bupropion HCL XL 300 mg tablets. The delivery order has a firm fixed price of $60,566.68 and an ultimate completion date of January 17, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order is likely a task order issued under that broader IDC. The contract does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $60.6k | 1/16/24 |